Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr948 Inhibitors

Olfr948, a member of the olfactory receptor family 8 subfamily G, is integral to the olfactory system in Mus musculus, functioning as a G-protein-coupled receptor (GPCR). These receptors are pivotal for initiating the perception of smell by binding to odorant molecules and triggering neuronal responses. Olfr948, like its counterparts in the olfactory receptor family, features a 7-transmembrane domain structure, which is essential for its role in odorant recognition and signal transduction. The ability of Olfr948 to selectively bind to specific odorant molecules and initiate a cascade of intracellular events underscores its critical role in the olfactory system's capacity to distinguish a wide array of scents. Inhibiting Olfr948's function can be achieved through direct or indirect methods. Direct inhibition would involve blocking the receptor's interaction with its specific odorant ligands, preventing the activation of the associated G-protein and the subsequent signal transduction pathway. This type of inhibition requires a high degree of specificity to ensure targeted action without affecting other GPCRs. Indirect inhibition encompasses a broader approach, including modulation of the receptor's membrane dynamics or conformation, which can influence its ability to interact with ligands or activate G-proteins. Additionally, targeting downstream signaling pathways or regulatory mechanisms of the receptor can alter its activity. For example, influencing the intracellular pathways that regulate receptor desensitization, internalization, or recycling can significantly impact the receptor's signaling efficacy. The chemical inhibitors listed in the table represent potential indirect inhibitors of Olfr948, each acting through different mechanisms, such as cytochrome P450 enzyme inhibition, modulation of neurotransmitter receptors, and alteration of G-protein coupling. The exploration of the function and inhibition mechanisms of Olfr948 contributes significantly to our understanding of GPCR-mediated signal transduction in the olfactory system. The specificity and diversity of olfactory receptors, including Olfr948, highlight the complexity of targeting these receptors for modulation. Both direct and indirect inhibition strategies provide crucial insights into the molecular dynamics of olfactory transduction and the broader implications of GPCR modulation in sensory biology. Understanding these mechanisms is key to deciphering the complex network of interactions governing olfactory perception and exploring potential modulation of these processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fexofenadine

83799-24-0sc-218475
100 mg
$292.00
1
(0)

Fexofenadine, a selective H1 antihistamine, indirectly modulates GPCR signaling. By blocking histamine action, it reduces the modulation of GPCR activity, potentially decreasing Olfr948 signaling in olfactory pathways.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol, a non-selective beta-adrenergic blocker, impacts GPCR-mediated signaling. This can lead to altered G-protein coupling efficiency in receptors like Olfr948, indirectly affecting their olfactory signal transduction.

(RS)-Atenolol

29122-68-7sc-204895
sc-204895A
1 g
10 g
$77.00
$408.00
1
(1)

Atenolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr948 function.

Omeprazole

73590-58-6sc-202265
50 mg
$66.00
4
(1)

(S)-Omeprazole Sodium Salt, a proton pump inhibitor, can indirectly modulate GPCR activity. By affecting gastric acid secretion, it influences the histamine-mediated modulation of GPCRs, potentially impacting Olfr948 signaling.

Nebivolol

99200-09-6sc-279910
100 mg
$803.00
1
(0)

Nebivolol, a selective beta-1 adrenergic blocker, modulates GPCR signaling pathways indirectly. Its action on beta-1 receptors can affect G-protein coupling in related GPCRs, potentially impacting Olfr948.

Amiodarone

1951-25-3sc-480089
5 g
$312.00
(1)

Amiodarone, primarily an antiarrhythmic, can influence GPCR function due to its interaction with multiple receptors. This can lead to indirect modulation of GPCR signaling pathways, potentially affecting Olfr948.